SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Magnetic stimulation (nTMS) gives brain surgeons new insight Pre-operative brain mapping may reduce brain surgery damage

Imagining a less-invasive surgery with MRI-powered millirobots Is injecting 'millirobots' into patient spinal canals the future?

Testing equipment: Still a challenge, but getting easier Testing equipment is getting easier but no less a challenge

GE Healthcare launches Vscan Access portable ultrasound for developing regions Aims to reduce pregnancy related deaths worldwide

Proton therapy's real-world benefits accrue at PTCOG Measuring appropriate use and untapped potential with two new studies

Study confirms patient preference for receiving imaging results The referring doctor is seen as best source of info, although a majority of patients also want to view their radiology report

Announcing the 'Rosetta Stone' of advanced prostate cancer Researchers say prostate cancer not a "single disease" but 90 percent of cases yield actionable mutations

Surgical robotic device market to grow over 600 percent by 2021 Will jump from $3.2 billion to $20 billion

New radiation blood test awaits human application Research funded by feds to save lives offers faster, cheaper testing

Scientists embed electrodes in yarn, paving the way for true wearable devices 'Wearing your heart on your sleeve' may take on a whole new meaning

Siemens' new Biograph mCT Flow
with FlowMotion™ technology

SNMMI 13: Siemens introduces two new technologies to molecular imaging

by Carol Ko , Staff Writer
On June 10th at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Vancouver, British Columbia, Siemens Healthcare unveiled two new systems that constitute a big leap forward for molecular imaging, according to the company.

First, the German engineering firm debuted its Biograph mCT Flow PET/CT system — the world's first continuous motion PET/CT system.

Story Continues Below Advertisement

Joint Commission changes are here! Are YOU ready?

As the leading Joint Commission accreditation service provider in the U.S., WEST PHYSICS knows these new requirements in depth. Click here to find out how WEST PHYSICS can help guide you successfully through the process.



The machine is designed to address the problems physicians encountered with regular PET/CT stop-and-go image acquisition, which often requires additional overlapping scans in areas of the body that require higher image resolution, such as the head and neck.

A continuous motion system eliminates this problem by slowing down and gathering higher counts in areas of the body that demand it, while speeding through other parts of the body that require less attention, such as the legs.

"Now we can customize and adapt these scans to the personal anatomy of the patient," said James Williams, CEO of the molecular imaging unit at Siemens.

Additionally, in static stop-and-go acquisition, any part of the body captured at the edges of the detector's field of vision may be subject to loss of accuracy.

Continuous motion scanning eliminates this problem because each part of the body passes through the detector's "sweet spot" at least once, allowing for more accurate images.

Siemens has also debuted another new system called the Symbia Intevo, which aims to overcome some of the long-standing limitations of traditional SPECT/CT by totally integrating SPECT and CT, resulting in what the company is calling a brand new modality — xSPECT.

Though traditional SPECT/CT mechanically fuses SPECT and CT images together, the inherent mismatch between SPECT and CT requires that SPECT be used as the starting frame of reference, resulting in a degradation of CT's anatomical specificity.

Using new advanced detector technology, Symbia Intevo is able to look to CT as the common frame of reference, giving doctors valuable anatomical detail that may help them differentiate cancer from other forms of disease, which is notoriously difficult to do in traditional SPECT/CT.

"We're not not only able to diagnose the level of the problem but what is causing the problem in each specific patient," said Dr. Jerry Froelich, director of nuclear medicine and molecular imaging at University of Minnesota.

According to Siemens, the accuracy of this system also allows physicians to do something on SPECT/CT that it couldn't do before: quantification.

Though therapeutic monitoring had always been the aim of SPECT/CT, the modality's lack of fine accuracy has hindered its use for this purpose. Now, according to Siemens, this may finally change with the debut of xSPECT and its ability to quantify disease.

Biograph mCT Flow has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), and Symbia Intevo is currently pending clearance.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED